Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial
莫努匹拉韦治疗免疫功能低下患者的 COVID-19:来自 3 期随机、安慰剂对照 MOVe-OUT 试验的疗效、安全性和病毒学结果
期刊:Infection
影响因子:3.6
doi:10.1007/s15010-022-01959-9
Johnson, Matthew G; Strizki, Julie M; Brown, Michelle L; Wan, Hong; Shamsuddin, Hala H; Ramgopal, Moti; Florescu, Diana F; Delobel, Pierre; Khaertynova, Ilsiyar; Flores, José F; Fouche, Leon F; Chang, Shan-Chwen; Williams-Diaz, Angela; Du, Jiejun; Grobler, Jay A; Paschke, Amanda; De Anda, Carisa